Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
H. Lundbeck A/S clinical trials
The registry lists 276 studies whose lead sponsor is H. Lundbeck A/S or one of 10 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.
Keep track of what changes. Save the H. Lundbeck A/S studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to H. Lundbeck A/S.
- H. Lundbeck A/S224 studiesSame company
Something wrong?
- Chelsea Therapeutics16 studies →Acquired — became part of H. Lundbeck A/S, Jun 23, 2014 · source ↗
Something wrong?
- Lundbeck LLC9 studies →Acquired
Something wrong?
- Alder Biopharmaceuticals, Inc.6 studies →Acquired — became part of H. Lundbeck A/S, Oct 22, 2019 · source ↗
Something wrong?
- Abide Therapeutics6 studies →Acquired
Something wrong?
- Longboard Pharmaceuticals6 studies →Acquired — became part of H. Lundbeck A/S, Dec 2, 2024 · source ↗
Something wrong?
- Prexton Therapeutics3 studies →Acquired
Something wrong?
- Lundbeck Canada Inc.3 studies →Regional office
Something wrong?
- Saegis Pharmaceuticals1 study →Acquired
Something wrong?
- Lundbeck Italia S.p.A.1 study →Regional office
Something wrong?
- Lundbeck Japan K. K.1 study →Regional office
Something wrong?
Focus areas
Conditions H. Lundbeck A/S leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 276. Browse all 276 →
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic MigraineRecruitingNCT04965675Phase 3
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)Enrolling by invitationNCT06908226Phase 3
Sponsor listed in the registry: Longboard Pharmaceuticals · First submitted after Longboard Pharmaceuticals became part of H. Lundbeck A/S
- A Study of Eptinezumab in Pediatric Participants With Episodic MigraineRecruitingNCT05897320Phase 3
- A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigraineRecruitingNCT05164172Phase 3
- A Trial of Lu AH69593 in Healthy ParticipantsRecruitingNCT07775261Phase 1
- An Extension Trial of Asedebart in Participants With Congenital Adrenal HyperplasiaNot yet recruitingNCT07859293Phase 2
- A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor FluctuationsRecruitingNCT07514858Phase 2
- A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have NarcolepsyRecruitingNCT07613710Phase 1
- A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)RecruitingNCT07513441Phase 1
- A Trial of Lu AG13909 in Participants With Congenital Adrenal HyperplasiaRecruitingNCT05669950Phase 1/2
- Intermediate-Size Expanded Access Protocol (EAP) for LP352AvailableNCT06149663
Sponsor listed in the registry: Longboard Pharmaceuticals · First submitted before Longboard Pharmaceuticals became part of H. Lundbeck A/S
- A Trial of Lu AG13909 in Adult Participants With Cushing's DiseaseActive, not recruitingNCT06471829Phase 2
- A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)Active, not recruitingNCT06706622Phase 3
- A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)Active, not recruitingNCT06660394Phase 3
Sponsor listed in the registry: Longboard Pharmaceuticals · First submitted before Longboard Pharmaceuticals became part of H. Lundbeck A/S
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)Active, not recruitingNCT06719141Phase 3
Sponsor listed in the registry: Longboard Pharmaceuticals · First submitted the day Longboard Pharmaceuticals became part of H. Lundbeck A/S
- A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP MedicationsCompletedNCT06701526Phase 4
- A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye DiseaseActive, not recruitingNCT06557850Phase 1
- A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsCompletedNCT06323928Phase 2
- A Study of Lu AF82422 in Participants With Multiple System AtrophyActive, not recruitingNCT05104476Phase 2
- Lu AF28996 in Participants With Parkinson's Disease (PD)CompletedNCT04291859Phase 1
- A Study of Eptinezumab in Participants With Migraine and Medication Overuse HeadacheCompletedNCT05452239Phase 4
- Eptinezumab as Preventive Treatment of Migraine in Adults With MigraineCompletedNCT04921384Phase 3
- Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in JapanCompletedNCT05064371Phase 3
- Observational Study in Multiple System AtrophyActive, not recruitingNCT05453058
- Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyCompletedNCT05626634Phase 2
Sponsor listed in the registry: Longboard Pharmaceuticals · First submitted before Longboard Pharmaceuticals became part of H. Lundbeck A/S
- A Trial Investigating Lu AG09222 With Ubrogepant in Participants With MigraineCompletedNCT06578585Phase 1
- A Study Investigating Lu AG06474 in Healthy Young ParticipantsTerminatedNCT05943327Phase 1
- A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian AdultsCompletedNCT06258720Phase 1
- Study to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesCompletedNCT05364021Phase 1/2
Sponsor listed in the registry: Longboard Pharmaceuticals · First submitted before Longboard Pharmaceuticals became part of H. Lundbeck A/S
- A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy MenCompletedNCT06337110Phase 1
- Eptinezumab in Participants With Episodic Cluster HeadacheCompletedNCT04688775Phase 3
- A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)CompletedNCT05064397Phase 3
- A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult ParticipantsCompletedNCT06077786Phase 1
- A Trial Investigating Lu AF28996 in Healthy Adult ParticipantsCompletedNCT06277609Phase 1
- Real World Effectiveness of Eptinezumab in Participants With MigraineTerminatedNCT05284019Phase 4
- Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of CarbidopaCompletedNCT00983814Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsCompletedNCT05133323Phase 2
- Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed ConditionsCompletedNCT03670095Phase 1
- Bioequivalence Study to Compare Two Formulations of Deanxit®CompletedNCT03472651Phase 1
- Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With FibromyalgiaCompletedNCT01323374Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)CompletedNCT06004180Phase 1
- A Study in Children and Young People With Migraine to Learn What the Body Does to EptinezumabCompletedNCT04537429Phase 1
- A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive TreatmentsCompletedNCT04418765Phase 3
- A Study Investigating Lu AG22515 in Healthy AdultsCompletedNCT05136053Phase 1
- Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic HypotensionCompletedNCT02586623Phase 4
- Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's DiseaseCompletedNCT04149860Phase 1
- Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)CompletedNCT04597450Phase 1
- A Study to Evaluate Lu AF90103 in Healthy MenTerminatedNCT04940949Phase 1
- A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple SclerosisTerminatedNCT04990219Phase 1